Association Between Serum Concentrations of (Certain) Metals and Type 2 Diabetes Mellitus

Magdalena Tyczyńska,Gabriela Hunek,Weronika Kawecka,Adam Brachet,Marta Gędek,Kinga Kulczycka,Katarzyna Czarnek,Jolanta Flieger,Jacek Baj
DOI: https://doi.org/10.3390/jcm13237443
IF: 3.9
2024-12-07
Journal of Clinical Medicine
Abstract:The findings regarding trace element concentrations in patients diagnosed with type 2 diabetes and healthy controls are inconsistent, and therefore, we determined to gather them in the form of a review to further indicate the need for more advanced knowledge development. In our study, we reviewed articles and studies that involved the topics of micronutrient and metal associations with the occurrence and development of type 2 diabetes. We mainly included works regarding human-based studies, but with limited research results, animal-based research was also taken into account. With some newer studies, we reached for initial assumptions of previous statements. The results indicated that higher serum levels of lead, cadmium, arsenic, bromine, barium, strontium, nickel, aluminum, calcium, copper, and ferritin are positively associated with diabetic prevalence. Both too-low and too-high levels of zinc, selenium, and magnesium may be connected to the development of diabetes. Chromium has the capability of insulin response modulation, with enhanced insulin-cell binding, and thus, lower serum levels of chromium can be found in diabetic patients. There are contradictory discoveries regarding manganese. Its supplementation can possibly cease the development of insulin resistance and type 2 diabetes. On the contrary, other studies reported that there is no such connection. Our work indicates that, as micronutrients play a significant role in the pathogenesis of metabolic disorders, more research regarding their bodily homeostasis and type 2 diabetes should be conducted.
medicine, general & internal
What problem does this paper attempt to address?